Pramipexole

Pramipexole: Talking Openly About Impulse Control Disorders

Pramipexole is a dopamine agonist: it mimics the messenger substance dopamine in the brain and is used in Parkinson's disease and, at a much lower dose, in restless legs syndrome. One of its most important side effects is something hardly anyone mentions of their own accord: impulse control disorders such as gambling addiction, compulsive shopping, binge eating or a greatly increased sex drive. Recognised early, they can usually be brought under control well — provided patients and their families know what to look out for.

See more detail

Pramipexole: notice changes early, not just their consequences

Record doses, sleep, mood and anything unusual in one history — free in the brite app.

Track pramipexole

1. At a Glance: Technical Data Sheet

PropertyDetails
Active ingredientPramipexole (as pramipexole dihydrochloride monohydrate)
ATC codeN04BC05
Drug classDopamine agonist without an ergot structure (non-ergot agonist), acting mainly at D2 and D3 receptors
Dosage formsImmediate-release tablets (in Parkinson's usually three times a day), prolonged-release tablets (once a day)
Half-lifeAbout 8 hours in younger people, up to about 12 hours in older age; excreted mainly unchanged via the kidneys
Maximum daily doseAccording to the SmPC, 3.3 mg pramipexole base in Parkinson's (equivalent to 4.5 mg salt), 0.54 mg base in restless legs syndrome (equivalent to 0.75 mg salt)
Onset of effectIn Parkinson's, gradually over the weeks of dose titration; in restless legs syndrome often noticeable within a few days
Prescription statusPrescription-only medicine
Notable featureStrength is stated either as base or as salt; impulse control disorders and sudden sleep attacks are possible; never stop abruptly
Table scrolls to the right

2. How it works: mimicking dopamine rather than supplying it

In Parkinson's disease, the brain lacks the messenger substance dopamine. There are two ways of making up for this: you supply the precursor from which the remaining nerve cells make dopamine themselves — that is levodopa. Or you act directly on the receiving sites (receptors) and mimic dopamine — that is what dopamine agonists such as pramipexole do.¹

Because pramipexole does not depend on conversion in nerve cells and works considerably longer than levodopa, it stimulates the receptors more evenly. That is its strength: fewer fluctuations in effect and fewer excess movements in the first few years. Its weakness: it is less effective than levodopa against the movement symptoms and has more psychological side effects.²

The key to these side effects lies in its receptor preference. Pramipexole acts particularly strongly at the D3 receptors, which are concentrated in the brain's reward system — where motivation, desire and pleasure arise. If this system is stimulated continuously, impulses that would otherwise be kept in check can gain the upper hand. This explains why gambling, shopping or binge eating occur much more often with dopamine agonists than with levodopa.³

In restless legs syndrome (RLS), pramipexole acts on the dopamine system, which is involved there in producing the urge to move — at a fraction of the Parkinson's dose. This article covers both areas of use; the conditions themselves are described in the linked articles.

No ergot, no heart valve worries. Older dopamine agonists with an ergot structure (ergot agonists) could cause connective tissue changes in the heart valves and lungs. Pramipexole does not belong to this group; the regular heart ultrasound checks that were needed with those medicines are not required.

3. Dosing: base, salt and two very different ranges

The figures below describe the approach given in the SmPC.¹ They are not a dosing recommendation — the dose and the pace of adjustment are set by the treating practice.

The base-salt trap

Pramipexole tablets carry two different numbers: the amount of pure active substance (base) and the amount of the salt in which it is present. The same tablet can therefore be labelled 0.18 mg (base) or 0.25 mg (salt). In Europe the base figure is usual; in other countries and in older documents you will often find the salt figure.¹ When the manufacturer changes, after a hospital stay or with medicines from abroad, this can easily lead to mix-ups. With every new pack, check whether the number matches your medication plan, and ask at the pharmacy if it differs.

  • Parkinson's: Treatment starts low and is increased in weekly steps until effect and tolerability are right. According to the SmPC, the usual maintenance dose lies within a wide range up to the maximum dose of 3.3 mg base daily.
  • Immediate-release or prolonged-release: The tablets are split into three doses, while the prolonged-release tablets are taken once a day. According to the SmPC, switching between the two forms at the same daily dose is possible, but it should be agreed with your practice.
  • Restless legs syndrome: A single, low evening dose about two to three hours before going to bed; the maximum dose is 0.54 mg base — one sixth of the maximum Parkinson's dose.
  • Combined with levodopa: If pramipexole is added to levodopa, the levodopa dose is often reduced to avoid excess movements.
  • Impaired kidney function: Because pramipexole is excreted almost entirely via the kidneys, the dose and dosing frequency are adjusted to kidney function — see section 10.

4. Taking it day to day

  1. With or without food — but regularly. Unlike with levodopa, protein plays no role in absorption. If you suffer from nausea at first, it is better to take the tablets with a meal.
  2. Fixed times. The prolonged-release tablet is taken at about the same time every day, the immediate-release tablets spread evenly over the day. A dose reminder in the brite app helps, especially during the titration phase, when the dose changes every week.
  3. Swallow prolonged-release tablets whole. Do not split, chew or crush them — otherwise the active ingredient is released all at once.
  4. Missed dose: The package leaflet gives a time window within which a dose can be taken late; after that, the dose is skipped. Never take a double amount.
  5. Note down changes. Sleep, daytime tiredness, mood, appetite, spending, time on your phone or computer: what seems trivial at first is an important early signal with dopamine agonists (section 6).
Sleep attacks and driving. Pramipexole can make you very tired during the day and, in rare cases, cause you to fall asleep suddenly without warning — even in the middle of an activity.¹ If this happens to you, you must not drive or operate dangerous machinery until it has been clarified with your practice. The combination with alcohol or sedatives is particularly risky. More in the guide medications and driving.

Dose titration without the confusion

A new dose every week? Reminders and your history adapt — and show what is changing.

Create a dose plan

5. Side effects: tiredness, oedema, hallucinations

Many side effects of pramipexole depend on the dose and are therefore rarer and milder in restless legs syndrome than in Parkinson's.¹

  • Nausea: common at the start, usually easing off. Taking it with food and increasing the dose slowly help.
  • Tiredness, drowsiness, sleep attacks: see the warning above. Sleep problems, vivid dreams and restlessness at night also occur — more on sleep disorders.
  • Dizziness and a drop in blood pressure on standing up: especially during dose titration — see low blood pressure.
  • Swollen legs: Water retention in the ankles and lower legs is common with dopamine agonists. It is usually harmless, but a doctor should rule out heart failure or a vein condition.
  • Hallucinations and confusion: especially in older people and at higher doses; they often begin with harmless illusions or the feeling that someone is in the room.
  • Excess movements: possible in combination with levodopa.
  • Weight changes: often as a result of binge eating — in which case they belong under section 6.
Get medical help straight away. Hallucinations with fear, delusions or aggression, acute confusion, high fever with muscle stiffness after a change of dose, or sudden shortness of breath with very swollen legs are not symptoms to wait out — go to your practice the same day, and if in doubt call 112 (emergency number in Germany). Do not stop pramipexole abruptly in the process (section 7).

6. Impulse control disorders: raise them openly before damage is done

This is the core of this article. On dopamine agonists, people can develop behaviours that were previously alien to them — and which they often do not connect with the medicine. The SmPC explicitly lists these impulse control disorders and requires that patients and their families are informed about them and asked about them regularly.¹ In a large study of people with Parkinson's, they occurred much more often in those taking dopamine agonists than in those who were not.³ They also occur in restless legs syndrome, though less often.

What forms there are

FormHow it can show
Pathological gamblingNew or sharply increasing gambling, online casinos, sports betting, the lottery in unusual amounts; losses are hidden or people try to "win them back"
Compulsive shoppingFrequent, unnecessary purchases, often online and at night; parcels that are hidden away; buying the same item several times
Binge eatingCravings, especially for sweet things, eating at night, rapid weight gain — see food cravings
Increased sexual desireMarkedly increased desire, new sexual interests, excessive use of pornography, pressure on a partner
Punding and hobbyismHours of aimless sorting, taking things apart or repeating the same activity; excessive preoccupation with a hobby
Table scrolls to the right

Why this is so rarely talked about

Impulse control disorders have three features that make them dangerous. First, they are associated with shame: hardly anyone talks about gambling debts or sexual changes without being asked. Second, the link with the medicine is often missing — people experience the behaviour as their own weakness or a change in character, not as a side effect. Third, those affected often do not notice the change themselves, or notice it late; it is their partner or their children who notice first.

Who is particularly at risk

  • Higher doses and longer treatment with dopamine agonists.
  • A younger age at onset and being male.
  • Previous addictions or impulsive behaviour, including in the family — such as gambling or alcohol problems.
  • Depression or anxiety disorders.

How to raise it

  1. Agree on it in advance. When treatment starts, talk to your family about the fact that this side effect is possible — and that they may raise it with you without it being an accusation.
  2. Take a family member along to appointments. Ideally, your practice asks about it specifically at every appointment; standardised questionnaires make this easier. Family members add what patients themselves do not see.
  3. Be specific. Not "I'm fine", but: "In the last few weeks I have been buying, gambling or eating more than before." Small changes count too.
  4. Report it early. The sooner your practice reacts, the smaller the financial, professional and family damage. In many cases the changes subside after a dose reduction or a switch of medicine.²
A safety net for families. While treatment is being adjusted, practical steps can limit the damage: daily limits on bank and credit cards, account access for a trusted person, removing saved payment details from online shops. For gambling, self-exclusion is possible via the nationwide German gambling exclusion system (OASIS), and addiction counselling centres offer free support. These measures are not a sign of mistrust but a form of protection that many people later describe as a relief.
Do not stop abruptly in alarm. When an impulse control disorder comes to light, the temptation to drop pramipexole immediately is great. That can trigger a withdrawal syndrome and a marked deterioration in mobility (section 7). Instead, contact the treating practice promptly; they can plan a reduction and, if necessary, a switch to levodopa. If there is acute danger to you or others — for example suicidal thoughts because of debts — call 112.

7. Reduce rather than stop: the agonist withdrawal syndrome

Pramipexole is never stopped abruptly. The SmPC describes two risks of stopping suddenly or reducing sharply:¹

  • A condition resembling neuroleptic malignant syndrome: high fever, muscle stiffness, impaired consciousness, unstable circulation — an emergency.
  • Dopamine agonist withdrawal syndrome: anxiety, panic attacks, low mood, lack of drive, exhaustion, sweating, pain and a strong craving for the medicine. These symptoms can occur even with a slow reduction and barely respond to levodopa.

That is why pramipexole is reduced step by step according to a plan set by your practice. If a withdrawal syndrome occurs, it may be necessary to slow the reduction or temporarily return to the previous dose. That is not failure but part of a safe approach. General principles are explained in the guide stopping medications.

Withdrawal or the underlying condition coming back? During the reduction it is often hard to tell whether restlessness and low mood are coming from withdrawal, from depression or from returning Parkinson's symptoms. A record of dose, mood, sleep and mobility helps your practice to tell them apart. In restless legs syndrome, the urge to move can temporarily come back more strongly when the medicine is stopped.

8. Restless legs: a low dose with a problem of its own

In restless legs syndrome, pramipexole often works quickly and reliably. The difficulty only shows up over time: augmentation. This means the symptoms get worse under treatment — they start earlier in the day, become stronger, set in more quickly at rest and spread to the arms.¹ The typical but wrong response is to increase the dose, which drives the augmentation further.

Because of this risk, the recommendations have shifted. The American Academy of Sleep Medicine now advises against using dopamine agonists such as pramipexole routinely as standard treatment for restless legs syndrome, and puts more emphasis on correcting iron deficiency and on active ingredients such as gabapentin or pregabalin.⁴ For people who are already well controlled on pramipexole without augmentation, this does not mean they have to switch — but it does mean that the dose and course should be reviewed regularly.

  • Have your iron levels checked — low iron stores intensify RLS symptoms and encourage augmentation.⁴ Whether topping up with iron supplements makes sense is decided by your practice; background under iron deficiency anaemia.
  • Note when symptoms start — if the start slips from late evening into the afternoon, that is an early sign of augmentation.
  • Do not increase the dose yourself — if the effect is wearing off, ask your practice rather than taking a second tablet.
  • Watch out for impulses here too — impulse control disorders are rarer in restless legs syndrome, but they do occur.

9. Interactions

Pramipexole is hardly broken down in the liver at all; it is mostly excreted unchanged via the kidneys. Classic interactions via liver enzymes therefore play hardly any role. What matters most are dopamine antagonists, sedating medicines and substances that slow excretion via the kidneys.¹

CombinationConsequenceWhat to do
Antipsychotics and metoclopramideBlock dopamine — the effect of pramipexole is cancelled out and Parkinson's symptoms get worseAvoid; for psychosis only selected substances such as quetiapine come into question
Sleeping tablets and sedatives, sedating antidepressantsIncreased tiredness, more sleep attacks, risk of fallsOnly after seeking advice
AlcoholIncreases tiredness and the tendency to fall asleepHold back; see medications and alcohol
Cimetidine, amantadineCan slow excretion via the kidneys, so the pramipexole level risesWatch for side effects, have the dose checked by a doctor
LevodopaMore excess movements and hallucinations possibleThe levodopa dose often needs adjusting
Blood pressure lowering medicinesGreater drop in blood pressure on standing upCheck blood pressure while standing
Table scrolls to the right

The most common stumbling block in everyday life is metoclopramide for nausea — a medicine that is often given routinely in emergency departments and after operations. If you take pramipexole, mention it with every new prescription. The interaction check in the brite app flags dopamine antagonists and sedating combinations in your list.


10. Special cases: kidneys, older age, pregnancy, eyes

Impaired kidney function

Because pramipexole is excreted almost entirely via the kidneys, its level rises as kidney function declines. The SmPC therefore provides for adjusting the dose and dosing frequency.¹ With chronic kidney disease, or if kidney values worsen in older age, the pramipexole dose should be reviewed. General information in the guide medications for kidney and liver disease.

Older people

In older age, hallucinations, confusion and daytime tiredness occur more often with dopamine agonists. The guideline therefore tends to see levodopa as the first choice in older people.² If you already take pramipexole, have your medication reviewed if new memory problems, confusion at night or falls occur — do not stop it on your own.

Pregnancy and breastfeeding

Experience in pregnancy is limited; according to the SmPC, it should only be taken after a strict weighing of benefits and risks.¹ Pramipexole inhibits the milk-producing hormone prolactin and can suppress milk production; it is therefore usually not used while breastfeeding. For restless legs syndrome, which is more common in pregnancy, other measures come first.

Eyes and mental health

The SmPC recommends having an eye examination if vision problems occur and having your eyes checked at regular intervals.¹ In severe mental illness, especially psychosis, pramipexole is only used with great caution.


11. Pramipexole experiences: what patients really ask

"My husband has been sitting at his tablet at night for weeks and has gambled money away. Could it be his Parkinson's medicine?"

Yes, that is possible, and it is important that you raise it. Pathological gambling is a known side effect of dopamine agonists such as pramipexole. The change is not a character flaw and is usually not deliberately hidden — many people do not connect it with the medicine at all. Make an appointment at the neurology practice soon, and ideally go along too. Do not stop the medicine yourself, but in the meantime protect your finances, for example with card limits and a gambling self-exclusion.

"I secretly eat sweets in the evening and have put on ten kilos. Is it just frustration?"

Perhaps, but not necessarily. Binge eating, especially with cravings for sweet things, is one of the impulse control disorders that occur with dopamine agonists. If the change began after pramipexole was started or increased, that is an important clue for your practice. Weight gain on pramipexole should therefore always be raised — even if it feels embarrassing.

"Since the dose has been reduced I feel wretched and anxious, even though I am moving well."

That may be a dopamine agonist withdrawal syndrome. It shows up more in the mind than in the body: anxiety, panic, low mood, exhaustion, sometimes pain and sweating. Levodopa hardly helps against it. Raise the symptoms quickly; the reduction is often slowed down. If you have suicidal thoughts or unbearable anxiety, you need help immediately — via your practice, the out-of-hours medical service on 116 117 or 112.

"My restless legs now start in the afternoon, when it used to be only at night. Should I increase the dose?"

Please do not do this on your own. An earlier start, stronger symptoms or spreading to the arms point to augmentation — a typical long-term consequence of dopaminergic RLS medicines. A higher dose usually makes it worse. Your practice will check your iron levels and consider whether a change of treatment makes sense. Until your appointment, note every day when the symptoms start.

Metoclopramide, sleeping tablets, alcohol: what sedates, what blocks?

The interaction check shows dopamine antagonists and increased tiredness in your list.

Check your list

FAQ: Common questions about pramipexole

Yes. Like compulsive shopping, binge eating and increased sexual desire, pathological gambling is one of the known impulse control disorders on dopamine agonists. They occur much more often than with levodopa and in many cases subside after a dose reduction or a switch. It is important to raise them early and not to stop the medicine on your own.
Typical signs are new or sharply increasing spending, hidden parcels or debts, night-time activity on the computer or phone, cravings with weight gain, markedly changed sexual behaviour or hours of aimless sorting and tinkering. Those affected often do not notice the change themselves. Families should raise it openly and without reproach, and go along to appointments.
No. Stopping abruptly can trigger a condition with high fever and muscle stiffness that resembles neuroleptic malignant syndrome, as well as a withdrawal syndrome with anxiety, low mood and exhaustion. Pramipexole is reduced step by step according to a medical plan, even if side effects such as impulse control disorders are the reason.
The amount can be stated as the pure active substance (base) or as the salt. For example, 0.18 mg base corresponds to 0.25 mg salt. In Europe the base figure is usual. With new packs, check whether the figure matches your medication plan, and ask at the pharmacy if it differs.
Pramipexole can make you very tired and, rarely, cause you to fall asleep suddenly without warning. If you notice daytime tiredness or sleep attacks, you must not drive until this has been clarified by a doctor. Alcohol and sedatives increase the risk.
Augmentation means that the symptoms get worse under treatment: they start earlier in the day, become stronger and spread to the arms. It is a typical long-term consequence of dopamine agonists such as pramipexole. Increasing the dose usually makes it worse, so your practice should check your iron levels and consider a change of treatment.
Water retention in the ankles and lower legs is common with dopamine agonists and usually harmless. However, a doctor should rule out heart failure or a vein condition. With shortness of breath or rapidly increasing swelling, a prompt examination is needed.

Sources

  1. Summary of Product Characteristics (SmPC) for pramipexole (tablets and prolonged-release tablets; current version, available through the German medicines information system). pharmnet-bund.de
  2. S2k guideline on Parkinson's disease (German Society of Neurology, DGN, 2023) — German source. awmf.org
  3. Weintraub D et al.: Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Archives of Neurology, 2010. jamanetwork.com
  4. American Academy of Sleep Medicine (AASM): The treatment of restless legs syndrome and periodic limb movement disorder — clinical practice guideline. Journal of Clinical Sleep Medicine, 2025. jcsm.aasm.org

Manage dopamine agonists safely — with brite

A dose plan, a sleep and mood history and an interaction check in one place. Free.

Create medication plan
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. Never stop pramipexole abruptly and do not reduce the dose on your own — not even if impulse control disorders or other side effects are the reason; report them promptly to the treating practice instead. Do not increase the dose yourself in restless legs syndrome. Do not drive if you have sleep attacks. If you have hallucinations with fear, acute confusion, high fever with muscle stiffness or suicidal thoughts, contact a doctor straight away or, in an emergency, call 112. The choice of medicine and the dose are always set individually by the treating practice. Last updated: September 2026.